FMII
ALT icon

Farmers & Merchants Investments Inc’s Altimmune ALT Stock Holding History

Farmers & Merchants Investments Inc’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-227
Closed -$3K – 986
2021
Q3 		$3K Buy
227
+90
+66% +$1.09K ﹤0.01% 889
2021
Q2 		$1K Buy
+137
New +$1.87K ﹤0.01% 915

Other funds holding ALT

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Farmers & Merchants Investments Inc's ALT Position: Q4 2021 in Review

Farmers & Merchants Investments Inc sold out of Altimmune (ALT) in Q4 2021, closing a stake of 227 shares — an estimated $3K sold.

Farmers & Merchants Investments Inc first reported a position in ALT in Q2 2021 and held it in 2 quarters. The position peaked at $3K in Q3 2021. 102 funds tracked by Wall St. Rank hold ALT as of Q4 2021.

  • Farmers & Merchants Investments Inc reported no remaining Altimmune position as of Q4 2021 after selling out during the quarter.
  • Farmers & Merchants Investments Inc sold 227 Altimmune shares in Q4 2021, an estimated $3K.
  • Farmers & Merchants Investments Inc first reported a position in Altimmune in Q2 2021 and held it in 2 quarters.
  • Farmers & Merchants Investments Inc's Altimmune position peaked at $3K in Q3 2021.
  • 102 funds tracked by Wall St. Rank held Altimmune as of Q4 2021.

Based on Farmers & Merchants Investments Inc's 13F filing for Q4 2021, filed 14 Jan 2022.